mented
mental
atment
▁spon
▁shor
▁uptake
ocytes
▁quantit
▁inflamm
erated
▁sampl
namic
ocaine
ocl
▁mucosa
itro
▁systemic
ronch
▁irradi
▁suppression
▁intake
▁hormone
leu
▁phenotype
asive
ergy
ilic
▁renal
erate
ectomy
▁saline
armac
tial
stolic
▁hepar
▁physici
nec
lymph
▁correlated
▁fetal
▁hypox
▁valve
immun
▁urine
ults
▁prolonged
▁LDL
lux
▁predic
▁pancre
▁remo
▁hep
▁transient
omal
mia
▁injections
▁embry
acr
▁discus
▁venous
ogra
▁hepat
▁recor
ximal
veolar
alian
▁tox
ilateral
ituitary
▁perfusion
▁transplantation
▁glycoprotein
▁inhibitors
utaneous
▁hypertensive
loid
EG
▁excre
▁effic
▁statistically
▁inhibitory
rox
lym
sia
ration
▁clus
vic
ycin
ulatory
▁tumors
▁hepatocytes
asal
▁bronch
bral
▁diffic
▁Bec
▁labeling
ayed
dominal
▁glomerular
▁ischemia
▁predominantly
ficial
▁smo
▁metabolism
▁Patients
▁atrial
▁chlor
lood
▁memb
ethyl
▁rati
▁preferen
▁IgM
icin
▁localized
▁artery
osal
MV
uted
▁follic
▁vitro
oprote
▁infections
▁morphology
enic
adder
▁stenosis
▁lesions
idne
▁exis
▁reduc
tum
ints
▁onset
eric
tic
▁neph
lusion
▁diabetic
▁inten
genic
▁lar
▁stimuli
▁markers
▁proliferation
▁physiological
▁Tran
▁injur
▁elic
geal
mend
▁arter
tical
crib
▁olig
ostic
tation
▁reproduc
▁establ
LV
ocar
▁impair
▁metabol
▁incidence
eded
▁experim
▁mortality
▁leuk
DH
▁glyc
▁cereb
▁catheter
▁vascular
tage
▁BP
odynamic
rents
▁acute
ocytic
▁carcin
▁ethanol
trib
taining
gth
operative
otropic
aneously
▁chemotherapy
▁hypot
▁disapp
vely
▁bloc
ctive
▁potency
▁detectable
▁exogenous
▁infarction
▁polym
aline
Ca
▁concentrations
▁reac
▁secretion
▁ultras
tro
▁vein
tensive
▁scre
▁provid
▁bac
ovascular
lyc
▁TGF
atitis
ometr
▁fas
▁chloride
ygen
▁aden
▁techniqu
▁neurop
tors
▁phy
▁glomer
entical
oplas
▁decreas
pir
▁receptor
▁IgG
aemia
▁prevalence
lastic
▁pancreatic
▁excretion
tent
tin
ditions
▁molecule
tero
▁cardi
▁elimin
urine
▁carbohyd
▁severity
▁sten
▁deli
stim
DNA
▁abnormalities
sess
▁alterations
▁opi
▁neon
bility
estig
atients
▁compart
▁dietary
lec
▁ischemic
▁tes
▁cathe
▁impaired
▁aortic
ergic
▁specificity
ialysis
▁preparations
▁membrane
▁exer
▁adhe
monary
sive
kely
▁infants
▁acids
associated
▁parame
▁inflammatory
▁locus
oic
anding
▁poten
▁amin
tained
orac
▁transi
▁estrogen
duce
▁numb
▁confir
▁glucose
oplasm
▁biop
▁bladder
▁deficiency
tak
dition
▁previ
▁necrosis
owever
▁cardiac
▁quantitative
▁pati
▁prol
urther
▁pulmonary
▁comple
▁proteins
▁ach
▁pituitary
osin
▁mutations
ucle
▁complications
loro
▁restric
cine
▁hypertension
sensitive
ociation
▁platelet
ologic
▁tissues
keletal
▁pH
▁therapeutic
▁ovari
anol
hemical
tein
▁extre
induced
▁pla
▁assay
ture
idation
yroid
chol
▁bir
▁gastric
▁arteries
▁specimens
duced
▁increas
trol
▁oste
duction
▁ventricular
qui
▁sulf
natal
▁gradi
tion
▁repres
oglyc
▁ratios
quid
helial
▁hemodynamic
erative
opro
▁gluc
▁skeletal
seud
▁randomized
iol
▁synthesis
mature
toc
▁Ig
▁pneum
▁hepatic
▁maternal
opathy
▁valu
rophob
▁studi
otyp
hyd
otor
kele
atid
olysis
▁angi
▁ana
▁malign
▁criter
gative
iatric
itant
oplasmic
ogenous
vity
▁bene
acet
inic
oscop
▁hepatitis
▁reperfusion
ochemical
▁glut
clo
▁biopsy
▁ure
▁heparin
▁nucleus
▁monit
roph
angl
▁intraven
ropriate
▁decreased
▁lesion
osomal
ociated
▁accumulation
▁clinically
sion
▁cann
▁serum
tinu
▁metast
plantation
athe
▁injected
pendent
▁rhy
tact
▁intra
▁peripheral
odies
reas
▁Addition
mentation
▁lymph
▁receptors
gland
▁implic
▁hypothe
utions
monstr
▁abnormal
▁supple
RH
▁shif
▁stren
▁doses
▁fatty
▁pharmac
echan
ocyte
▁dex
▁induction
lob
ameth
▁intravenous
▁antibodies
▁toxicity
bly
ignific
▁differenti
onate
▁undergo
scop
▁LV
viron
▁attrib
▁carcinoma
entif
ocyt
▁aor
▁vaccin
tration
▁kidney
▁distin
▁distrib
▁reas
▁HLA
▁underst
▁throm
▁combin
▁gangl
▁cardiovascular
▁immun
▁melan
▁adequ
▁challen
echn
▁neonatal
▁elevated
▁perip
phrine
▁tran
▁infusion
osom
▁interv
▁thyroid
▁selective
▁graft
▁enti
▁haem
ilized
tive
▁nec
▁tiss
▁ovarian
rine
▁thromb
▁distal
▁ischem
▁stimul
▁molec
▁inhibit
▁benz
radi
▁responsiveness
▁AMP
▁surgical
▁tumor
▁atten
tif
▁cervical
▁uter
▁gland
▁inhibition
▁chan
cence
▁iso
imens
▁arterial
reast
spective
orrh
▁wee
oprotein
▁progn
tions
eared
▁metabolic
▁avail
▁occurrence
dose
▁vitamin
▁elevation
▁stimulation
otrop
▁cate
entral
▁efficacy
onary
▁spontaneous
▁malignant
▁urinary
▁contrib
▁hypo
▁differen
itamin
sych
▁reper
▁RA
yro
sible
feren
▁symptom
ritis
▁myocardial
itone
▁dysfunction
▁cyt
▁fibers
▁spinal
▁infar
▁tumour
▁stu
estion
▁Treatment
iotic
▁analyses
Ig
▁insulin
▁lipoprotein
▁systolic
eration
▁beha
▁lipid
▁endothelial
ymp
▁bypass
ectom
fusion
dle
positive
tis
emia
pine
MN
ortic
▁identif
▁muc
▁recom
▁agon
▁heterogene
▁differentiation
▁stimulate
▁requi
imin
▁trac
▁neutroph
▁postoperative
▁cerv
▁ventric
illary
▁agonist
▁examin
▁evoked
▁cerebral
▁assays
▁coronary
rosis
▁tas
▁antic
▁somat
▁mediated
phal
▁medial
▁chol
BV
treatment
tur
▁simult
▁synthe
▁pathway
▁mono
